The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksANW.L Regulatory News (ANW)

  • There is currently no data for ANW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Aberdeen New Thai Inv Trust (ANW)

1 Feb 2021 08:00

RNS Number : 3704N
Aberdeen New Thai Inv Trust PLC
29 January 2021
 

 

London, UK, 1 February 2021

 

 Edison issues review on Aberdeen New Thai Investment Trust (ANW)

Aberdeen New Thai Investment Trust (ANW) is the only London-listed investment trust focused on investing in Thailand and the manager Aberdeen Standard Investments (ASI) believes the Thai equity market remains inefficient. During 2020, the ANW team rebalanced the portfolio. ANW was not well positioned for the unforeseen pandemic and subsequent market rout, and performance disappointed. Nevertheless, the manager picked up undervalued stocks during the 2020 sell-off. The manager expects quality companies within the rebalanced portfolio that are market leaders to better weather the impacts of the pandemic and generate sustainable long-term returns.

 

ANW trades on a 15.4% discount to its cum-income NAV, wider than its three-year average of 14.0%, and a significant recovery from the March 2020 low (21.7%). Its double-digit gearing amplified the portfolio's underperformance in 2020, but means ANW should see improving performance as the country recovers and investors refocus on Thailand's brighter longer-term prospects within Asia.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Victoria Chernykh, +44 (0)20 3681 2522, investmenttrusts@edisongroup.com

Sarah Godfrey, +44 (0)20 3681 2519, investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLMMTMTJTBLB
Date   Source Headline
14th Jan 202110:44 amRNSPortfolio disclosure
13th Jan 202111:47 amRNSNet Asset Value(s)
12th Jan 202111:08 amRNSNet Asset Value(s)
11th Jan 202111:49 amRNSGearing disclosure
11th Jan 202111:14 amRNSNet Asset Value(s)
8th Jan 20214:38 pmRNSTransaction in Own Shares
8th Jan 202111:05 amRNSNet Asset Value(s)
7th Jan 20213:12 pmRNSMonth End Net Asset Value(s)
7th Jan 202111:26 amRNSNet Asset Value(s)
6th Jan 202112:20 pmRNSNet Asset Value(s)
5th Jan 202111:29 amRNSNet Asset Value(s)
4th Jan 20212:45 pmRNSGearing disclosure
4th Jan 202110:39 amRNSTotal Voting Rights
31st Dec 202012:35 pmRNSNet Asset Value(s)
30th Dec 202011:04 amRNSNet Asset Value(s)
29th Dec 20202:30 pmRNSGearing Disclosure
29th Dec 202012:08 pmRNSNet Asset Value(s)
24th Dec 202011:31 amRNSNet Asset Value(s)
23rd Dec 202011:46 amRNSNet Asset Value(s)
22nd Dec 202011:34 amRNSNet Asset Value(s)
21st Dec 20205:01 pmRNSTransaction in Own Shares
21st Dec 20202:34 pmRNSGearing disclosure
21st Dec 202011:53 amRNSNet Asset Value(s)
18th Dec 202012:09 pmRNSNet Asset Value(s)
17th Dec 202012:12 pmRNSNet Asset Value(s)
16th Dec 202010:56 amRNSNet Asset Value(s)
15th Dec 202011:14 amRNSNet Asset Value(s)
14th Dec 20203:46 pmRNSGearing disclosure
14th Dec 202012:20 pmRNSNet Asset Value(s)
14th Dec 202011:10 amRNSPortfolio disclosure
11th Dec 202012:34 pmRNSNet Asset Value(s)
10th Dec 202012:30 pmRNSNet Asset Value(s)
9th Dec 202011:05 amRNSNet Asset Value(s)
8th Dec 202011:48 amRNSNet Asset Value(s)
7th Dec 202012:09 pmRNSGearing Disclosure
7th Dec 202011:09 amRNSNet Asset Value(s)
4th Dec 20202:30 pmRNSMonth End Net Asset Value(s)
4th Dec 202011:13 amRNSNet Asset Value(s)
3rd Dec 202012:39 pmRNSNet Asset Value(s)
2nd Dec 20203:45 pmRNSQuarterly disclosure
2nd Dec 20201:15 pmRNSNet Asset Value(s)
1st Dec 20209:50 amRNSTotal Voting Rights
30th Nov 20202:57 pmRNSGearing disclosure
30th Nov 202011:54 amRNSNet Asset Value(s)
27th Nov 202012:47 pmRNSNet Asset Value(s)
26th Nov 202012:22 pmRNSNet Asset Value(s)
25th Nov 202012:52 pmRNSNet Asset Value(s)
24th Nov 202012:42 pmRNSNet Asset Value(s)
23rd Nov 20201:23 pmRNSGearing disclosure
23rd Nov 202012:50 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.